The biosimilar and follow-on biologics market has been segmented into Europe, North America, Latin America, the Middle East & Africa, and Asia Pacific. Europe among these regional areas has been projected to hold a noticeable share in the market owing to a significant increase...
Biosimilar and Follow-On Biologics Market - Global Industry Size, Trends, Analysis And Forecasts 2012 - 2018Ketan
The proportion of MP patients decreased from 98% at 2 months to 34% at 2 years. MP patients (n = 32) had similar DAS28 to non-MP patients (n = 53) at initial visits, lower DAS28 and greater DAS28 improvements at follow-ups (P≤ 0.05 at visits 4, 6, 7 and 9) and reached s...